TOUJEO DOUBLESTAR

Google image searchProduct monograph

Active ingredient

insulin glargine, 300 UNIT/ML

DIN: 02493373

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 3 ML (900 IU) PREFILLED PEN

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 04-FEB-2020

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE04 — INSULIN GLARGINE (ATC/DDD)

Reference brand drug: Lantus, Basaglar, Semglee, Toujeo

Pharmaceutical standard: MFR

External Links for Toujeo Doublestar

Search on Google

• Toujeo Doublestar side effects
• Toujeo Doublestar dosage
• insulin glargine side effects
• insulin glargine dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find toujeo doublestar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.